European Medicines Agency (EMA) | What's new Follow Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 1, Status: Authorised https://www.ema.europa.eu/en/medicines/human/EPAR/svariya ema.europa.eu
